12:00 AM
Dec 07, 2009
 |  BC Week In Review  |  Company News  |  Other News

La Jolla Pharma autoimmune news

La Jolla will seek options other than liquidation after failing three times to convene enough shareholders to vote on the liquidation proposal. The company said that about 92% of shareholders did not return a...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >